Cargando…

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature

BACKGROUND: Multicentric Castleman’s disease is a life-threatening disorder involving a systemic inflammatory response and multiple organ failure caused by the overproduction of interleukin-6. Although renal complications of Castleman’s disease include AA amyloidosis, thrombotic microangiopathy, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saiki, Ryosuke, Katayama, Kan, Hirabayashi, Yosuke, Oda, Keiko, Fujimoto, Mika, Murata, Tomohiro, Nakajima, Ayako, Dohi, Kaoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191014/ https://www.ncbi.nlm.nih.gov/pubmed/34107915 http://dx.doi.org/10.1186/s12882-021-02423-w

Ejemplares similares

Three Weeks of Treatment Induced Long-term Remission in a Patient with Micrococcus luteus-related Peritonitis
por: Saiki, Ryosuke, et al.
Publicado: (2022)

Mutation Analysis of Thin Basement Membrane Nephropathy
por: Hirabayashi, Yosuke, et al.
Publicado: (2022)

Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients
por: Suzuki, Yasuo, et al.
Publicado: (2023)

Mother–Son Kidney Transplantation in Patients With X-Linked Alport Syndrome
por: Katayama, Kan, et al.
Publicado: (2021)

Bullous Pemphigoid in X-linked Alport Syndrome
por: Yamawaki, Masahiro, et al.
Publicado: (2022)

Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature
por: Miura, Shoko, et al.
Publicado: (2023)

Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models
por: Saiki, Ryosuke, et al.
Publicado: (2023)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

Acute kidney injury due to thin basement membrane disease mimicking Deferasirox nephrotoxicity: a case report
por: Oda, Keiko, et al.
Publicado: (2018)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

High-flow arteriovenous fistula in X-linked Alport syndrome: a case report
por: Takahashi, Daisuke, et al.
Publicado: (2023)

Granulomatous interstitial nephritis due to chronic lymphocytic leukemia: a case report
por: Suzuki, Yasuo, et al.
Publicado: (2017)

Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022)

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)

Improvement of Alveolar Hemorrhaging in an Elderly and Renally Impaired Patient with Relapsing Anti-neutrophil Cytoplasmic Autoantibody-associated Vasculitis by Single Infusion of Rituximab
por: Oda, Keiko, et al.
Publicado: (2018)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012)

Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
por: Han, Ping-Yang, et al.
Publicado: (2020)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Type VI collagen-related nephropathy
por: Mori, Mutsuki, et al.
Publicado: (2022)

Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report
por: Sugawara, Eri, et al.
Publicado: (2022)

A Perihilar Variant of Focal Segmental Glomerulosclerosis Due to De novo Branchio-oto-renal Syndrome
por: Saiki, Ryosuke, et al.
Publicado: (2021)

Candidate biomarkers for idiopathic multicentric Castleman disease
por: Sumiyoshi, Remi, et al.
Publicado: (2022)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Disruption of the glomerular basement membrane associated with nutcracker syndrome and double inferior vena cava in Noonan syndrome: a case report
por: Omori, Ayumi, et al.
Publicado: (2022)

Multicentric Castleman disease with infiltration of eosinophils to the lung
por: Nakai, Shogo, et al.
Publicado: (2021)

IgM-Positive Tubulointerstitial Nephritis Associated With Asymptomatic Primary Biliary Cirrhosis
por: Mizoguchi, Shoko, et al.
Publicado: (2018)

A Case of Multicentric Castleman's Disease Having Lung Lesion Successfully Treated with Humanized Anti-interleukin-6 Receptor Antibody, Tocilizumab
por: Higuchi, Tomoaki, et al.
Publicado: (2010)

Randomized, double-blind, placebo-controlled, parallel-group trial of sirolimus for tocilizumab-resistant idiopathic multicentric Castleman disease: Study protocol for clinical trial
por: Koga, Tomohiro, et al.
Publicado: (2020)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG(4)-positive plasma cells: A case report
por: Katsumata, Yusuke, et al.
Publicado: (2018)

Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases
por: Komaba, Hirotaka, et al.
Publicado: (2008)

HIV-associated multicentric Castleman's disease
por: Naime, Fauzia de Fátima, et al.
Publicado: (2012)

Multicentric Castleman disease and the evolution of the concept
por: Zhou, Ting, et al.
Publicado: (2021)

An open-label continuation trial of sirolimus for tocilizumab-refractory idiopathic multicentric Castleman disease: Study protocol for an investigator-initiated, multicenter, open-label trial (SPIRIT compliant)
por: Koga, Tomohiro, et al.
Publicado: (2020)

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases
por: Nagao, Azusa, et al.
Publicado: (2014)

Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series
por: Kojima, Daiki, et al.
Publicado: (2023)

A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy
por: Nakajima, Shuhei, et al.
Publicado: (2023)

Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan
por: Masaki, Yasufumi, et al.
Publicado: (2019)

Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature
por: Pan, Yuejuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_klk417l5uriedveacgs7mqdj0f